法搜网--中国法律信息搜索网
国家食品药品监督管理局药品安全监管司关于举办世界卫生组织疫苗预认证申报程序培训班暨疫苗生产企业座谈会的通知


  Ⅲ.       Managerial, administrative, commercial and regulatory infrastructure

  Q1: Does your pricing policy cover the full cost of each vaccine produced?
  □ No
  □ Yes

  Q2: Does the company have a business plan?
  □ No
  □ Yes

  Q3: If the answer to the previous question is yes what is the period covered by the plan
  □ One year
  □ Two years
  □ Three or more years

  Q4: Does the company have a mechanism to conduct research on future demand in terms of types and quantity of products required in the market?
  □ No
  □ Yes

  Q5: Does the company have control to hire and fire staff as necessary
  □ No
  □ Yes

  Q6: Does the company have control over revenues?
  □ No
  □ Yes

  Q7: Does the company have control to set salary policy?
  □ No
  □ Yes

  Q8: Does the company have a regulatory affairs department?
  □ No
  □ Yes

  Q9: If the answer to the previous question is yes, what is the role of the regulatory affairs department

  Briefly explain:

  Q10: Does the company have a commercial department?
  □ No
  □ Yes

  Q11: If the answer to the previous question is yes, what is the role of the commercial department?

  Briefly explain:

  IV. Quality Systems including GMP/QA

  Q1: Does the company have a maintenance programme in place with allocated budget?
  □ No
  □ Yes

  Q2: Does the company have a Master validation plan?
  □ No
  □ Yes

  Q3: Does the company have an established Quality Assurance Unit?
  □ No
  □ Yes

  Q4: If the answer to the previous question is yes, what is the role of the QA unit?

  Briefly explain:

  Q5: Is the company inspected for GMP compliance by NRAs from foreign countries?


第 [1] [2] [3] [4] [5] [6] [7] [8] 页 共[9]页
上面法规内容为部分内容,如果要查看全文请点击此处:查看全文
【发表评论】 【互动社区】
 
相关文章